News

The fields of artificial intelligence (AI) and biotechnology are experiencing rapid advancements, and their convergence is expected to create significant opportunities in the future. The application of AI in biotechnology has the potential to accelerate drug discovery, provide precise...

Monash University- Australia has gone on to buy a prominent Parkville property that will go on to become a major addition to its campus, which is home to the world-leading Faculty of Pharmacy and Pharmaceutical Sciences, and thereby unprecedentedly...

The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership...

A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an appealing market for investment. AstraZeneca defies geopolitics to bet on China – Financial Times (paywalled) AstraZeneca's CEO...

As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is expected to CAGR (experience a compound annual growth rate) of 8.4 percent between 2023 and...

Centogene, a life science company based in Germany that specializes in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company owned by the Public Investment Fund (PIF), have joined forces in a strategic collaboration. They have formed a Joint Venture...

2022 was an unremarkable year for biotech mergers and acquisitions (M&A) as the industry experienced a decline in both the number and value of deals. This was mainly due to economic and geopolitical uncertainties, causing potential buyers to exercise...